Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Unilabs finalises high multiple acquisition

Pan-European Switzerland-based lab group Unilabs has finalised the acquisition of a smaller French competitor, Biopath, for what we think is the highest multiple the consolidating French lab market has seen so far. Healthcare Europa names the price. 
November 15, 2018

Garofalo’s IPO likely to worry Big Three

Family-owned Italian hospital and nursing home operator Garofalo's listing on the Milan Stock exchange fetched a smaller price than market watchers may have expected. What does its multiple mean for the trio of Italian groups waiting in the wings to IPO?
November 15, 2018

Centene bets on the survival of the Alzira model

Spanish hospital group Ribera Salud is going back to its Spanish PPP roots with the acquisition of a hospital (through its owner Centene) in Madrid, despite recently looking to Eastern Europe and LatAm for profits after its core, Alzira model ran into difficulty in Valencia.
November 15, 2018

Retreating NHS leads to growth in private dermatology market

The medical dermatological market in the UK is worth £2bn and growing 10% annually. Demand is high, but we hear stretched NHS resources have been reducing supply. Earlier in the year, the NHS announced it would stop funding some procedures including the removal of benign skin lesions, and waiting lists for dermatological treatments are growing. We speak to a UK-based PE firm about resulting growth in the  UK private dermatological market.
November 15, 2018

Falck and co-investors offer entree to Russian hospital market

We talk to the Chairman of the Falck Vladivostok Hospital who says the international emergency care provider and co-investors are looking to sell and that there’s a bargain to be had for the willing buyer. Whilst an ambitious plan to build a Pan-Russian chain of budget hospitals was abandoned by the current investors, that plan could still offer an entree to the fast-growing Russian market.
November 15, 2018

Diaverum enters Macedonia

Soon-to-sell global dialysis service provider Diaverum has bought Macedonia's largest operator, with the CEO adding it could be a platform for further expansion in the region. We talk to Diaverum, dig further into the Macedonian dialysis market and disclose the revenue of the acquired company.
November 13, 2018

NephroPlus acquires DaVita India

India's largest dialysis operator NephroPlus has further consolidated the national market with the acquisition of global dialysis giant DaVita's Indian operations. We talk to NephroPlus CEO Vikram Vuppala about the deal and the Indian dialysis market.
November 7, 2018

KKR ‘nearing deal to buy Acadia’

The American press is reporting that US-based private equity giant KKR is ‘nearing a deal’ to buy addiction treatment specialists Acadia Healthcare. The purchase would bring one of America's largest PE giants into the UK healthcare industry for the first time. How are KKR's international healthcare investments fairing?
November 7, 2018
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us